Graphene Manufacturing Group Ltd (TSX-V:GMG, OTCQX:GMGMF) announced that its THERMAL-XR graphene coating solution is being applied to air conditioning units at two luxury residential towers under construction on Australia’s Gold Coast in Queensland.
The project involves coating between 300 and 600 air conditioners at GMG’s spray booth facility in Brisbane.
Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF, FRA:3XS0) has announced that Craig Hallworth will succeed Stephen Twyerould as president and CEO as part of a planned leadership transition, alongside a series of executive and technical appointments aimed at advancing the company’s flagship Gunnison Copper Project.
Hallworth, who is currently serving as the company’s senior vice president and chief financial officer, will officially assume the CEO role on May 15.
NanoViricides (NYSE-A:NNVC) is pointing to its lead drug candidate NV-387 as a potential solution to a critical gap in infectious disease preparedness, as a deadly hantavirus outbreak aboard a cruise ship triggers a costly global containment effort.
The Connecticut-based clinical-stage company said NV-387 has completed Phase I clinical trials for safety and tolerability in healthy volunteers and has shown effectiveness against multiple virus families in lethal animal models, including coronaviruses, RSV, influenza, monkeypox and measles, tested via the same respiratory route through which Andes hantavirus spreads.
Bit Digital Inc (NASDAQ:BTBT) announced Monday it has appointed Daniel Kennedy as its new head of investor relations.
Kennedy, a former board member, advisor, and director at publicly listed digital asset, fintech, and AI infrastructure companies, brings experience across capital markets and institutional investor relations. He also has a background in digital assets, blockchain infrastructure, and AI/HPC markets.
Shares in Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) rose 2.3% to 1,800p on Monday as investors weighed a first-quarter update in which record gold prices delivered strong financial results.
Revenue rose 18.3% year-on-year to $66.43 million, EBITDA jumped 50.2% to $33.87 million and profit after tax climbed 69.4% to $18.91 million, all driven by an average realised gold price of $4,816 per ounce, up 66.3% on the same period last year.
Dotlines Global (AIM: DOTL), a technology group spanning telecommunications, digital infrastructure, cybersecurity and financial technology, has begun trading on AIM following the completion of a reverse takeover that valued the business at £55.7 million.
The company was admitted under the ticker DOTL, with 609.3 million shares in issue giving a market capitalisation of £57.9 million at the acquisition price of 9.5 pence per share.
Empire Metals Ltd (AIM:EEE, OTCQX:EPMLF) has raised £8 million from existing institutional shareholders to accelerate development work at its Pitfield Titanium Project in Western Australia.
The AIM-quoted and OTCQX-traded resource company issued 26.7 million new shares at 30p each, giving it a pro-forma cash position of around £14.5 million on completion.
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) announced it has secured its 20% working interest in Namibia’s PEL 93 on an unconditional basis while cutting about $15 million of minimum future funding exposure under an amended farm-in agreement.
The AIM- and ASX-listed explorer said the revised deal with operator Monitor Exploration cancels Stage 2 and Stage 3 farm-in obligations, removes reassignment risk and simplifies the original commercial structure.
Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF) told investors that it has consented to Elevra Lithium transferring its rights and obligations in the Ewoyaa Lithium Project to Zhejiang Huayou Cobalt, potentially simplifying the funding route for Ghana’s flagship lithium development.
Elevra currently holds rights to a 22.5% interest in Atlantic’s Ghana lithium portfolio, including Ewoyaa, after meeting the Stage 2 terms of the project agreement.
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received a Canadian patent approval covering the use of its POLB 001 drug candidate in preventing cancer immunotherapy-induced cytokine release syndrome (CRS), a potentially life-threatening immune overreaction triggered by certain cancer treatments.
The grant is the second national approval within Poolbeg's CRS patent family, following a ruling by IP Australia in March 2026.
Lindian Resources Ltd (ASX:LIN, OTC:LINIF) has strengthened its executive and operational leadership team with seven new appointments across legal, sustainability, supply chain, health and safety, technology, finance and investor relations as the company pushes towards first production at its Kangankunde Rare Earths Project in Malawi.
The appointments come as Lindian transitions from project developer to future producer, with construction at Kangankunde well advanced and first production from both the Malawi upstream operation and the company’s planned SARECO hydrometallurgical facility in Kazakhstan targeted for Q4 2026.
Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) has begun flow-back and clean-up operations at the Diona-1 exploration well in Queensland’s Surat-Bowen Basin after successfully completing stimulation and well completion activities.
The Diona-1 well, in which Elixir holds a 49% operating interest alongside joint venture partner Xstate Resources Limited (ASX:XST, FRA:XW7), has been stimulated across identified Permian net gas pay zones and completed with 2-3/8-inch tubing and sliding sleeve completions.
Riversgold Ltd (ASX:RGL, FRA:RGV, OTC:RVSGF) has strengthened its land position at the Kalgoorlie Gold Project in Western Australia through a binding agreement to acquire 100% of granted tenement P25/2850.
The acquisition increases the project area by 20% to 10.22 square kilometres from 8.36 square kilometres, adding ground immediately north of the company’s Northern Zone porphyry gold project.